Both in Pharmaceuticals
Jade Biosciences vs Syndax Pharmaceuticals
Over the past year JBIO returned +67.1% and SNDX returned −31.9%; their daily moves had a correlation of 0.23.
JBIO +67.1% SNDX −31.9%Growth of $1, one year, split-adjusted
| Metric | JBIO | SNDX |
|---|---|---|
| Price | $15.04 | $10.45 |
| Market cap | $956.5M | $933.2M |
| Today | +3.23% | −26.87% |
| 1 month | +12.2% | −39.8% |
| 6 months | −40.2% | −49.4% |
| Year to date | −2.5% | −50.3% |
| 1 year | +58.8% | −24.1% |
| Revenue growth (YoY) | — | +81.6% |
| Gross margin | — | 83.2% |
| Net margin | — | −59.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.2× |
| Net cash | $461.2M | $182.3M |
| Dividend yield | — | — |
| Volatility (60d) | 52.6% | 84.0% |
| Short % of float | 20.7% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).